Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

435
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
435
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

972
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
972
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

853
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
853
Cancer Therapies02:49

Cancer Therapies

10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

529
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
529

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revisiting the obesity paradox in heart failure: what is the best anthropometric index to gauge obesity?

European heart journal·2023
Same author

Bone status in men with heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure.

European journal of heart failure·2023
Same author

Response by Schulze et al to Letter Regarding Article, "Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF)".

Circulation·2023
Same author

Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization: a European multinational economic evaluation.

European journal of heart failure·2023
Same author

Effects of a 2-year exercise training on neuromuscular system health in older individuals with low muscle function.

Journal of cachexia, sarcopenia and muscle·2023
Same author

Little at a time: trying to understand the battery of benefits of sodium-glucose contransporter 2 inhibitors in heart failure.

European journal of heart failure·2023
Same journal

Downstream Pathways of Dystrophin Deficiency in Duchenne Muscular Dystrophy: Implications for Muscle Degeneration and Regeneration.

Journal of cachexia, sarcopenia and muscle·2026
Same journal

Brain-Derived Neurotrophic Factor, Sarcopenia and Digital Gait Characteristics in Older Adults: Insights Into the Brain-Muscle Axis.

Journal of cachexia, sarcopenia and muscle·2026
Same journal

Functional Outcomes and Quality of Life for Patients With Cachexia and Solid Tumour Cancers: Findings of a Systematic Literature Review.

Journal of cachexia, sarcopenia and muscle·2026
Same journal

Comment on 'Asian Reference Values for Handgrip Strength, Gait Speed, Five-Times-Sit-to-Stand Test, Muscle Mass and Calf Circumference' by Grgic et al.-The Authors' Reply.

Journal of cachexia, sarcopenia and muscle·2026
Same journal

Deletion of Tgf-β1 From CD206<sup>+</sup> M2 Macrophages Ameliorates Obesity-Induced Suppression of Myogenesis and AMPK Phosphorylation in Skeletal Muscle.

Journal of cachexia, sarcopenia and muscle·2026
Same journal

First Evaluation of Ultrafast Ultrasound Coupled With Phrenic Stimulation for Noninvasive Diagnosis of Diaphragm Dysfunction.

Journal of cachexia, sarcopenia and muscle·2026
See all related articles

Related Experiment Video

Updated: Feb 28, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.3K

Highlights from the 9th Cachexia Conference.

Nicole Ebner1, Stephan von Haehling1

  • 1Department of Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany.

Journal of Cachexia, Sarcopenia and Muscle
|June 21, 2017
PubMed
Summary
This summary is machine-generated.

Updates on wasting disorders, including new therapeutic targets and diagnostic tools for skeletal muscle wasting, were presented at the 9th Cachexia Conference. Effective treatments are crucial for improving patient quality of life and survival.

Keywords:
CachexiaMuscle wastingSarcopenia

More Related Videos

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
05:30

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

279

Related Experiment Videos

Last Updated: Feb 28, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.3K
Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
05:30

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

279

Area of Science:

  • Wasting disorders research
  • Biomedical science
  • Clinical research

Background:

  • The 9th Cachexia Conference in Berlin (December 2016) focused on advancements in understanding and treating wasting disorders.
  • Significant progress in pre-clinical and clinical studies was presented, addressing critical unmet needs in patient care.

Framework:

  • The conference highlighted updated pathways involved in cachexia and related wasting conditions.
  • Exploration of novel therapeutic targets for effective intervention strategies was a key theme.

Implementation:

  • New diagnostic tools and cut-offs for detecting skeletal muscle wasting were discussed.
  • The biological and clinical significance of various biomarkers was presented, aiding in earlier and more accurate diagnosis.

Implications:

  • Findings underscore the urgent need for effective treatments to improve the quality of life for patients with wasting disorders.
  • Advancements in diagnostics and therapeutics hold the potential to enhance patient survival rates and overall outcomes.